These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. An essential role of myosin light-chain kinase in the regulation of agonist- and fluid flow-stimulated Ca2+ influx in endothelial cells. Watanabe H; Takahashi R; Zhang XX; Goto Y; Hayashi H; Ando J; Isshiki M; Seto M; Hidaka H; Niki I; Ohno R FASEB J; 1998 Mar; 12(3):341-8. PubMed ID: 9506478 [TBL] [Abstract][Full Text] [Related]
10. A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burns. Reynoso R; Perrin RM; Breslin JW; Daines DA; Watson KD; Watterson DM; Wu MH; Yuan S Shock; 2007 Nov; 28(5):589-95. PubMed ID: 17577141 [TBL] [Abstract][Full Text] [Related]
11. Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction and permeability via the mitogen-activated protein kinase pathway in a rabbit model of atherosclerosis. Ding J; Li Z; Li L; Ding Y; Wang D; Meng S; Zhou Q; Gui S; Wei W; Zhu H; Wang Y Biomed Pharmacother; 2020 Aug; 128():110258. PubMed ID: 32516749 [TBL] [Abstract][Full Text] [Related]
12. Involvement of RhoA and Rho kinase in neutrophil-stimulated endothelial hyperpermeability. Breslin JW; Yuan SY Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H1057-62. PubMed ID: 14630629 [TBL] [Abstract][Full Text] [Related]
13. The suppression of myosin light chain (MLC) phosphorylation during the response to lipopolysaccharide (LPS): beneficial or detrimental to endothelial barrier? Bogatcheva NV; Zemskova MA; Poirier C; Mirzapoiazova T; Kolosova I; Bresnick AR; Verin AD J Cell Physiol; 2011 Dec; 226(12):3132-46. PubMed ID: 21302311 [TBL] [Abstract][Full Text] [Related]